Search research articles
Contact Us
Filters
Showing results (121-130 of 155) with videos related to
Page
of 16
Sort By:
Clinical and Vaccine Immunology : CVI
|
April 12, 2013
B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination
Mark Y Sangster, Jane Baer, Felix W Santiago, et al.
Pathogens & Immunity
|
June 27, 2024
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
Bulletin of the World Health Organization
|
January 15, 2009
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals
Macarthur Charles, Francine Noel, Paul Leger, et al.
The Journal of Infectious Diseases
|
January 25, 2014
Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination
Peter F Wright, Wendy Wieland-Alter, Natalia A Ilyushina, et al.
AIDS Research and Treatment
|
December 31, 2014
Adapting and Implementing a Community Program to Improve Retention in Care among Patients with HIV in Southern Haiti: "Group of 6"
John A Naslund, Jodie Dionne-Odom, Cléonas Junior Destiné, et al.
The Lancet. Infectious Diseases
|
August 16, 2025
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial
Laina D Mercer, Arlene C Seña, E Ross Colgate, et al.
The Journal of Infectious Diseases
|
October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals
Ann R Falsey, Edward E Walsh, Jose Capellan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newborns
Audrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health
|
September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Nature Communications
|
August 24, 2023
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Andrew P Hederman, Harini Natarajan, Leo Heyndrickx, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 155) with videos related to
Sort By:
Page
of 16
Clinical and Vaccine Immunology : CVI
|
April 12, 2013
B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination
Mark Y Sangster, Jane Baer, Felix W Santiago, et al.
Pathogens & Immunity
|
June 27, 2024
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
Bulletin of the World Health Organization
|
January 15, 2009
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals
Macarthur Charles, Francine Noel, Paul Leger, et al.
The Journal of Infectious Diseases
|
January 25, 2014
Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination
Peter F Wright, Wendy Wieland-Alter, Natalia A Ilyushina, et al.
AIDS Research and Treatment
|
December 31, 2014
Adapting and Implementing a Community Program to Improve Retention in Care among Patients with HIV in Southern Haiti: "Group of 6"
John A Naslund, Jodie Dionne-Odom, Cléonas Junior Destiné, et al.
The Lancet. Infectious Diseases
|
August 16, 2025
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial
Laina D Mercer, Arlene C Seña, E Ross Colgate, et al.
The Journal of Infectious Diseases
|
October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals
Ann R Falsey, Edward E Walsh, Jose Capellan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newborns
Audrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health
|
September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Nature Communications
|
August 24, 2023
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Andrew P Hederman, Harini Natarajan, Leo Heyndrickx, et al.
Page
of 16